Skip to content

Clinical trials

Phase 3 Dermatitis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis Phase: Phase 3 Country / region: United States Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20101
20113
20122
20142
20182
20192
20203
20221
20234
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting3
Active, not recruiting2
Terminated2
Withdrawn2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals9
Eli Lilly and Company5
Pfizer5
Incyte Corporation4
Hordinsky, Maria K., MD1
NeoStrata Company, Inc.1
The University of Texas Health Science Center, Houston1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis26
Eczema13
Skin Diseases13
Dermatitis, Atopic10
Psoriasis6
Immune System Diseases4
Skin Diseases, Eczematous4
Skin Diseases, Genetic4
Plaque, Amyloid3
Genetic Diseases, Inborn2

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.